Victrelis (Boceprevir), a drug that is effective in treating hepatitis C genotype 1, has been approved for use in Australia. However, it has not been approved for subsidised access.
Update 21/03/12: Boceprevir (and Telaprevir) have not been approved for listing under the PBS, meaning no subsidised access yet. It may be available on a limited basis for some people. For more information, call 1300 437 222.
How're We Doing?
CNP at HepSA
Full range of free needles and syringes, plus water and filters for sale.